| pubmed-article:9585817 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9585817 | lifeskim:mentions | umls-concept:C1519025 | lld:lifeskim |
| pubmed-article:9585817 | lifeskim:mentions | umls-concept:C0023621 | lld:lifeskim |
| pubmed-article:9585817 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:9585817 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:9585817 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:9585817 | lifeskim:mentions | umls-concept:C0021031 | lld:lifeskim |
| pubmed-article:9585817 | lifeskim:mentions | umls-concept:C0751912 | lld:lifeskim |
| pubmed-article:9585817 | lifeskim:mentions | umls-concept:C0036576 | lld:lifeskim |
| pubmed-article:9585817 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9585817 | pubmed:dateCreated | 1998-6-3 | lld:pubmed |
| pubmed-article:9585817 | pubmed:abstractText | Antibodies against the HuD antigen expressed in small-cell lung cancer (SCLC) cross-react with proteins expressed in neurons of the central and peripheral nervous system and are associated with paraneoplastic encephalomyelitis and sensory neuropathy (PEM/SN). We isolated anti-HuD Fab fragments from an antibody phage display library that was constructed from mRNA of a metastatic lymph node from a patient with SCLC and Pem/SN. Fab GLN495 recognized HuD and other related proteins (HuC and Hel-N1, or Hu antigens) in immunoblots of these recombinant proteins and in immunohistochemical and Western blot analysis of SCLC and neurons. Fab GLN495 inhibited up to 75% of the anti-Hu antibodies of the patient from which it was derived, suggesting that recognizes a dominant epitope in the polyclonal anti-Hu antibody response. Fab GLN495 also competed with anti-Hu sera from most but not all patients with PEM/SN, indicating that the same epitope is recognized by a large subgroup of patients. Human monoclonal anti-HuD antibodies may be useful in diagnosis of HuD expressing tumors and in clarifying the autoimmune etiology of PEM/SN. This study, the first to demonstrate that tumor specific recombinant antibodies can be isolated from metastatic lymph node tissue, shows that this approach may be generally applicable to isolate human antibodies against tumor specific antigens. | lld:pubmed |
| pubmed-article:9585817 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9585817 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9585817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9585817 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9585817 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9585817 | pubmed:issn | 0165-5728 | lld:pubmed |
| pubmed-article:9585817 | pubmed:author | pubmed-author:van Breda... | lld:pubmed |
| pubmed-article:9585817 | pubmed:author | pubmed-author:PosnerJ BJB | lld:pubmed |
| pubmed-article:9585817 | pubmed:author | pubmed-author:BurtonD RDR | lld:pubmed |
| pubmed-article:9585817 | pubmed:author | pubmed-author:DalmasHH | lld:pubmed |
| pubmed-article:9585817 | pubmed:author | pubmed-author:GoetzHH | lld:pubmed |
| pubmed-article:9585817 | pubmed:author | pubmed-author:De BaetsM HMH | lld:pubmed |
| pubmed-article:9585817 | pubmed:author | pubmed-author:VerschuurenJ... | lld:pubmed |
| pubmed-article:9585817 | pubmed:author | pubmed-author:DegenhardtAA | lld:pubmed |
| pubmed-article:9585817 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9585817 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:9585817 | pubmed:volume | 82 | lld:pubmed |
| pubmed-article:9585817 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9585817 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9585817 | pubmed:pagination | 200-9 | lld:pubmed |
| pubmed-article:9585817 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:meshHeading | pubmed-meshheading:9585817-... | lld:pubmed |
| pubmed-article:9585817 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9585817 | pubmed:articleTitle | Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis. | lld:pubmed |
| pubmed-article:9585817 | pubmed:affiliation | Department of Immunology, Scripps Research Institute, La Jolla, CA USA. | lld:pubmed |
| pubmed-article:9585817 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9585817 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9585817 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9585817 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9585817 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9585817 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9585817 | lld:pubmed |
